Increased spending on biomedical R&D, the fast adoption of personalized medicine, and innovation in bio-inks and printing technologies are driving the global 3D bioprinting market.Austin, United ...
NORTHAMPTON, MA / ACCESS Newswire / February 4, 2026 / What You Need to KnowBiodiversity risk is more nuanced and complex ...
Core Laboratories Inc. (NYSE: "CLB") ("Core," "Core Lab," or the "Company") reported fourth quarter 2025 revenue of $138,300,000. Core's operating income was $15,800,000, with earnings per diluted ...
Exceeds fourth quarter revenue guidance and full year guidance across revenue, adjusted operating margin, and adjusted EPS Fourth quarter revenue of $5.3 billion increased 4.9% year-over-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results